Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 18, 2023

BUY
$8.79 - $14.58 $34,333 - $56,949
3,906 Added 5.58%
73,863 $694,000
Q4 2022

Jan 27, 2023

SELL
$11.49 - $13.65 $258,570 - $307,179
-22,504 Reduced 24.34%
69,957 $855,000
Q3 2022

Oct 18, 2022

SELL
$12.41 - $32.42 $30 Million - $78.5 Million
-2,420,470 Reduced 96.32%
92,461 $1.15 Million
Q2 2022

Jul 28, 2022

SELL
$19.63 - $26.62 $86.5 Million - $117 Million
-4,407,932 Reduced 63.69%
2,512,931 $49.3 Million
Q1 2022

Apr 22, 2022

SELL
$24.65 - $29.0 $860,309 - $1.01 Million
-34,901 Reduced 0.5%
6,920,863 $181 Million
Q4 2021

Jan 21, 2022

SELL
$27.74 - $34.09 $323,476 - $397,523
-11,661 Reduced 0.17%
6,955,764 $197 Million
Q3 2021

Oct 13, 2021

BUY
$29.2 - $36.72 $50.4 Million - $63.4 Million
1,727,460 Added 32.97%
6,967,425 $222 Million
Q2 2021

Jul 29, 2021

SELL
$28.76 - $35.98 $413,856 - $517,752
-14,390 Reduced 0.27%
5,239,965 $182 Million
Q1 2021

May 03, 2021

BUY
$27.85 - $34.49 $439,640 - $544,459
15,786 Added 0.3%
5,254,355 $155 Million
Q4 2020

Jan 25, 2021

BUY
$27.53 - $33.79 $3.37 Million - $4.14 Million
122,413 Added 2.39%
5,238,569 $161 Million
Q3 2020

Oct 22, 2020

BUY
$21.1 - $29.13 $41.5 Million - $57.3 Million
1,968,660 Added 62.55%
5,116,156 $143 Million
Q2 2020

Jul 21, 2020

BUY
$18.94 - $24.93 $1.93 Million - $2.54 Million
101,956 Added 3.35%
3,147,496 $67.5 Million
Q1 2020

Apr 28, 2020

BUY
$16.68 - $32.25 $21.2 Million - $41.1 Million
1,273,104 Added 71.83%
3,045,540 $68.2 Million
Q4 2019

Feb 10, 2020

BUY
$25.29 - $29.45 $24.7 Million - $28.8 Million
977,936 Added 123.09%
1,772,436 $52.2 Million
Q3 2019

Oct 24, 2019

BUY
$25.62 - $34.96 $20.4 Million - $27.8 Million
794,500 New
794,500 $21.1 Million

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.63B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Vantage Investment Partners, LLC Portfolio

Follow Vantage Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vantage Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vantage Investment Partners, LLC with notifications on news.